What is the prognosis for chronic myelomonocytic leukemia (CMML)?
The prognosis for CMML varies based on several factors, but overall survival rates differ significantly by subtype:
Survival Rates by CMML Type
- Type 0 or 1 CMML: About 20 percent of people live for five years or more after diagnosis
- Type 2 CMML: About Show Full Answer
What is the prognosis for chronic myelomonocytic leukemia (CMML)?
The prognosis for CMML varies based on several factors, but overall survival rates differ significantly by subtype:
Survival Rates by CMML Type:
- Type 0 or 1 CMML: About 20 percent of people live for five years or more after diagnosis
- Type 2 CMML: About 10 percent of people live for five years or more after diagnosis
Risk of Progression:
About 15 percent to 30 percent of people with CMML later develop acute myeloid leukemia (AML). The rate varies by subtype:
- Type 0 or 1 CMML: About 18 percent develop AML within five years
- Type 2 CMML: About 63 percent develop AML within five years
Factors That Influence Your Prognosis:
- Your age
- Whether you have other health conditions
- Your blood cell counts
- Which genetic changes your CMML cells have
- Your levels of lactate dehydrogenase (LDH)
- Your CMML subtype
Your healthcare team can help you understand how your individual characteristics affect your specific outlook with CMML.
AI-generated responses are not a substitute for medical advice. These services are not intended to
diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.
Chronic Myelomonocytic Leukemia: An Overview
January 22
I think you prognosis is going to be good because there are to effective medications that can control those bad cells. New medications are discovered every year and approved for use. I hope you get the answers to your questions so you can make a healthy choice.
January 23
Join
Your Privacy Choices
